In Silico and In Vitro Identification of 1,8-Dihydroxy-4,5-dinitroanthraquinone as a New Antibacterial Agent against Staphylococcus aureus and Enterococcus faecalis
Open Access
Abstract
Increasing rates of bacterial resistance to antibiotics are a growing concern worldwide. The search for potential new antibiotics has included several natural products such as anthraquinones. However, comparatively less attention has been given to anthraquinones that exhibit functional groups that are uncommon in nature. In this work, 114 anthraquinones were evaluated using in silico methods to identify inhibitors of the enzyme phosphopantetheine adenylyltransferase (PPAT) of Staphylococcus aureus, Enterococcus faecalis, and Escherichia coli. Virtual screenings based on molecular docking and the pharmacophore model, molecular dynamics simulations, and free energy calculations pointed to 1,8-dihydroxy-4,5-dinitroanthraquinone (DHDNA) as the most promising inhibitor. In addition, these analyses highlighted the contribution of the nitro group to the affinity of this anthraquinone for the nucleotide-binding site of PPAT. Furthermore, DHDNA was active in vitro towards Gram-positive bacteria with minimum inhibitory concentration (MIC) values of 31.25 µg/mL for S. aureus and 62.5 µg/mL for E. faecalis against both antibiotic-resistant isolates and reference strains but was ineffective against E. coli. Experiments on kill-time kinetics indicated that, at the tested concentrations, DHDNA produced bacteriostatic effects on both Gram-positive bacteria. Overall, our results present DHDNA as a potential PPAT inhibitor, showing antibacterial activity against antibiotic-resistant isolates of S. aureus and E. faecalis, findings that point to nitro groups as key to explaining these results.Keywords
Funding Information
- Universidad Católica de Cuenca (PICVII19-58)
This publication has 76 references indexed in Scilit:
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platformJournal of Cheminformatics, 2012
- Crystal Structure of Phosphopantetheine Adenylyltransferase from Enterococcus faecalis in the Ligand-Unbound State and in Complex with ATP and PantetheineMolecules and Cells, 2011
- The changing epidemiology of resistanceJournal of Antimicrobial Chemotherapy, 2009
- Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2008
- Phosphopantetheine Adenylyltransferase from Escherichia coli : Investigation of the Kinetic Mechanism and Role in Regulation of Coenzyme A BiosynthesisJournal of Bacteriology, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Bacterial resistance to antibiotics: Modified target sitesAdvanced Drug Delivery Reviews, 2005
- Coenzyme A: Back in actionProgress in Lipid Research, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Inhibition of Protein Kinase CK2 by Anthraquinone-related CompoundsJournal of Biological Chemistry, 2003